Werkgroep Cardiologische centra Nederland English

ACCELERATE (Afgerond)

Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High Risk for Vascular Outcomes (HRVD) – the ACCELERATE Study
Middel
evacetrapib
Populatie
ASCVD
Fase
III
Jaar aanvang
2012
Meer informatie
ClinicalTrials.gov

Studiedirecteur

drs. B.J.B. Hamer (Cardioloog)
Amersfoort, Meander Medisch Centrum